MX2009009211A - Metodo para reducir niveles de glucosa en sangre post-prandial con una composicion de proteina de suero de leche/fibra. - Google Patents

Metodo para reducir niveles de glucosa en sangre post-prandial con una composicion de proteina de suero de leche/fibra.

Info

Publication number
MX2009009211A
MX2009009211A MX2009009211A MX2009009211A MX2009009211A MX 2009009211 A MX2009009211 A MX 2009009211A MX 2009009211 A MX2009009211 A MX 2009009211A MX 2009009211 A MX2009009211 A MX 2009009211A MX 2009009211 A MX2009009211 A MX 2009009211A
Authority
MX
Mexico
Prior art keywords
blood glucose
glucose levels
postprandial blood
whey protein
reducing postprandial
Prior art date
Application number
MX2009009211A
Other languages
English (en)
Inventor
Raymond J Laudano
Julia Leigh Desrochers
Peter Harris Brown
Nathan V Matusheski
Kyle Maxwell Kamp
Andrew Edward Mcpherson
Original Assignee
Kraft Foods Global Brands Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kraft Foods Global Brands Llc filed Critical Kraft Foods Global Brands Llc
Publication of MX2009009211A publication Critical patent/MX2009009211A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Confectionery (AREA)
  • Dairy Products (AREA)

Abstract

Se provee un método que es efectivo para reducir los niveles de glucosa en sangre post-prandial. El método incluye administrar una mezcla física de proteína nativa de suero de leche y fibra viscosificante a un sujeto en una cantidad y un tiempo antes de una comida que son efectivos para reducir los niveles de glucosa en sangre post-prandial y/o reducir la ingesta de alimento.
MX2009009211A 2008-08-29 2009-08-28 Metodo para reducir niveles de glucosa en sangre post-prandial con una composicion de proteina de suero de leche/fibra. MX2009009211A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9303708P 2008-08-29 2008-08-29

Publications (1)

Publication Number Publication Date
MX2009009211A true MX2009009211A (es) 2010-03-25

Family

ID=41609795

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009009264A MX2009009264A (es) 2008-08-29 2009-08-28 Pre-carga de proteina de suero de leche.
MX2009009211A MX2009009211A (es) 2008-08-29 2009-08-28 Metodo para reducir niveles de glucosa en sangre post-prandial con una composicion de proteina de suero de leche/fibra.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2009009264A MX2009009264A (es) 2008-08-29 2009-08-28 Pre-carga de proteina de suero de leche.

Country Status (7)

Country Link
US (2) US20100056450A1 (es)
EP (2) EP2158918A1 (es)
CN (2) CN101816778A (es)
AR (2) AR073234A1 (es)
BR (2) BRPI0903042A2 (es)
CA (2) CA2676518A1 (es)
MX (2) MX2009009264A (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010033915A2 (en) * 2008-09-19 2010-03-25 Unicity International Inc. Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix
CN103874426A (zh) * 2011-08-16 2014-06-18 雅培制药有限公司 包括可溶性粘性纤维和含多酚的植物提取物的营养组合物
BR112014008692B1 (pt) * 2011-10-19 2022-01-18 Nutrition & Biosciences Usa 1, Llc Medicamento fluível ou ingerível por colher, alimento, ingrediente alimentício ou suplemento alimentar
AU2013204801B2 (en) 2012-05-23 2014-11-06 Omniblend Innovation Pty Ltd Composition and method for management of diabetes or pre-diabetes
WO2015074103A1 (en) * 2013-11-19 2015-05-28 Omniblend Innovation Pty Ltd Regimen and method for treatment of type 2 diabetes
AU2014353872B2 (en) * 2013-11-19 2020-05-14 Omniblend Innovation Pty Ltd Composition and method for control of post-prandial glucose
CN106307085A (zh) * 2016-05-30 2017-01-11 桂林澳妍科技有限公司 一种降血糖食品组合物
CN107279454B (zh) * 2017-06-20 2021-04-27 上海交通大学 一种新的粘性食品组合物及其制备方法
CN112040841A (zh) * 2018-04-18 2020-12-04 赞思健康科技有限公司 代谢监测系统
US11191289B2 (en) 2018-04-30 2021-12-07 Kraft Foods Group Brands Llc Spoonable smoothie and methods of production thereof
CN113368130B (zh) * 2021-06-25 2023-02-28 陕西科技大学 一种纤维状载铁复合物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1201321A (en) * 1981-12-22 1986-03-04 Anne-Marie Dahlen Protein-fruit drink
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5104676A (en) 1991-06-27 1992-04-14 Abbott Laboratories Weight control product
DK171752B1 (da) * 1992-07-06 1997-05-12 Birgitte Stilling Brødlignende produkt med blodsukkersænkende virkning til diabetikere samt pulverformig blanding til anvendelse ved fremstilling deraf
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US20020012733A1 (en) * 2000-04-12 2002-01-31 The Procter & Gamble Company Compositions for reducing hypercholesterolemia and controlling of postprandial blood glucose and insulin levels
US7326404B2 (en) * 2000-05-31 2008-02-05 Vuksan Holdings Inc. Konjac-mannan and ginseng compositions and methods and uses thereof
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
US8029818B2 (en) * 2001-05-31 2011-10-04 Abbott Laboratories Method of blunting the postprandial glycemic response to a meal
DK1395133T3 (da) * 2001-05-31 2006-08-21 Abbott Lab Af polymer kontrolleret system af fibre med fremkaldt viskositet og anvendelser deraf
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
US20040087514A1 (en) 2002-09-06 2004-05-06 Hughes Thomas E Nutritional compositions
AU2003287974B2 (en) * 2002-12-20 2007-10-25 Unilever Plc Blood glucose regulating composition
BRPI0412189A (pt) 2003-06-30 2006-08-22 Nestec Sa composição para tratar e/ou prevenir disfunções associadas à diabetes melito do tipo 2
US20050084578A1 (en) * 2003-10-16 2005-04-21 Onwulata Charles I. Food products containing texturized milk proteins
DE10352822A1 (de) * 2003-11-12 2005-06-23 Bioghurt Biogarde Gmbh & Co. Kg Verwendung einer zusätzlich fermentierten Getreideschlempe zur Vorbeugung und/oder Behandlung erhöhter Blutzucker-Werte
CN101018561A (zh) * 2004-07-19 2007-08-15 N·V·努特里奇亚 使用天冬氨酸和维生素b12或生物素调节酮体的制剂
US20060078593A1 (en) * 2004-09-27 2006-04-13 Strozier Deborah C Nutritional compostions comprising a soluble viscous fiber in a solid crisp matrix
US8062686B2 (en) * 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) * 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
EP1983849B1 (en) * 2006-01-20 2013-04-03 Innova Food AB A food composition comprising amino acids
US20090123580A1 (en) * 2007-10-17 2009-05-14 Nutracea Methods for treating obesity, insulin resistance and inducing satiety

Also Published As

Publication number Publication date
CN101816778A (zh) 2010-09-01
AR073235A1 (es) 2010-10-20
US20100056449A1 (en) 2010-03-04
CA2676955A1 (en) 2010-02-28
BRPI0903042A2 (pt) 2010-06-22
BRPI0902783A2 (pt) 2010-05-25
CN101669645A (zh) 2010-03-17
EP2158919A1 (en) 2010-03-03
CA2676518A1 (en) 2010-02-28
AR073234A1 (es) 2010-10-20
US20100056450A1 (en) 2010-03-04
MX2009009264A (es) 2011-08-10
EP2158918A1 (en) 2010-03-03

Similar Documents

Publication Publication Date Title
MX2009009211A (es) Metodo para reducir niveles de glucosa en sangre post-prandial con una composicion de proteina de suero de leche/fibra.
MX2012000943A (es) Metodos para atenuar la perdida de estatus funcional.
MX2013009948A (es) Composiciones de insulina y cromo para el tratamiento y prevencion de diabetes, hipoglucemia y alteraciones relacionadas.
NZ596037A (en) Fgf21 mutants and uses thereof
ES2571856T3 (es) Uso de composiciones nutricionales para prevenir la adiposidad visceral
MX2010000219A (es) Metodo de procesamiento de carne para aumentar la retencion de humedad.
NZ593297A (en) Myostatin binding proteins
MX2014005433A (es) Métodos y composiciones para modular bacterias gastrointestinales para promover la salud.
SG158112A1 (en) Hepatocyte growth factor (hgf) binding proteins
IN2012DN00760A (es)
WO2009151907A3 (en) Compositions and methods for using cells to treat heart tissue
BR112012033422A2 (pt) composições nutricionais de proteína alta, hipocalórica e métodos de usar as mesmas
HUP0800434A2 (en) Template to determine the places of the injections, especially for regular medicament injection and/or blood testing
WO2005113016A3 (en) Modulation of glucose-6-phosphatase translocase expression
MX2009008166A (es) Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
MX2020009677A (es) Composiciones preparadas de aves de corral y metodos de su uso.
PH12016500894A1 (en) Pediatric nutritional composition with milk peptides for healthy growth and development
BR112013009660A2 (pt) proteína de fusão com fator de atividade ix
EP2624707A4 (en) PROCESS FOR REDUCING THE OIL AND FAT CONTENT OF FOODS FOODS BY MEANS OF PEAS PROTEINS
WO2011143157A3 (en) Use of brown midrib corn silage in beef to replace corn
EA201290457A1 (ru) СЛИТЫЙ БЕЛОК BChE-АЛЬБУМИН ДЛЯ ЛЕЧЕНИЯ ЗЛОУПОТРЕБЛЕНИЯ КОКАИНОМ
MX2017000878A (es) Peptidos marinos y nucleotidos de pescado, composiciones y sus usos para reducir la glucosa en la sangre.
WO2013033366A3 (en) Methods and compositions for promoting glucose homeostasis
MX2007001075A (es) Metodo para la fabricacion de fibra de soya blanqueada.
TR201902764T4 (tr) Besin bileşimi, söz konusu besin bileşimini içeren gıda takviyesi ve söz konusu gıda takviyesini içeren kit.

Legal Events

Date Code Title Description
HC Change of company name or juridical status